Home/Filings/4/0001576885-24-000009
4//SEC Filing

OConnell Daniel Joseph 4

Accession 0001576885-24-000009

CIK 0001576885other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:18 PM ET

Size

329.3 KB

Accession

0001576885-24-000009

Insider Transaction Report

Form 4
Period: 2024-01-02
OConnell Daniel Joseph
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2024-01-02+401,000517,685 total
  • Award

    Employee Stock Option (right to buy)

    2024-01-02+602,000602,000 total
    Exercise: $4.23Exp: 2034-01-01Common Stock (602,000 underlying)
Footnotes (2)
  • [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.
  • [F2]The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.

Issuer

Acumen Pharmaceuticals, Inc.

CIK 0001576885

Entity typeother

Related Parties

1
  • filerCIK 0001865136

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:18 PM ET
Size
329.3 KB